| 000 | 01835 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250517155834.0 | ||
| 264 | 0 | _c20170719 | |
| 008 | 201707s 0 0 eng d | ||
| 022 | _a1524-4628 | ||
| 024 | 7 |
_a10.1161/STROKEAHA.116.015664 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aShkirkova, Kristina | |
| 245 | 0 | 0 |
_aParamedic Initiation of Neuroprotective Agent Infusions: Successful Achievement of Target Blood Levels and Attained Level Effect on Clinical Outcomes in the FAST-MAG Pivotal Trial (Field Administration of Stroke Therapy - Magnesium). _h[electronic resource] |
| 260 |
_bStroke _c07 2017 |
||
| 300 |
_a1901-1907 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAdministration, Intravenous |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 | _aEmergency Medical Technicians |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMagnesium _xblood |
| 650 | 0 | 4 |
_aMagnesium Sulfate _xadministration & dosage |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNeuroprotective Agents _xadministration & dosage |
| 650 | 0 | 4 | _aOutcome Assessment, Health Care |
| 650 | 0 | 4 |
_aStroke _xdrug therapy |
| 700 | 1 | _aStarkman, Sidney | |
| 700 | 1 | _aSanossian, Nerses | |
| 700 | 1 | _aEckstein, Marc | |
| 700 | 1 | _aStratton, Samuel | |
| 700 | 1 | _aPratt, Frank | |
| 700 | 1 | _aConwit, Robin | |
| 700 | 1 | _aHamilton, Scott | |
| 700 | 1 | _aSharma, Latisha | |
| 700 | 1 | _aLiebeskind, David | |
| 700 | 1 | _aRestrepo, Lucas | |
| 700 | 1 | _aValdes-Sueiras, Miguel | |
| 700 | 1 | _aSaver, Jeffrey L | |
| 773 | 0 |
_tStroke _gvol. 48 _gno. 7 _gp. 1901-1907 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1161/STROKEAHA.116.015664 _zAvailable from publisher's website |
| 999 |
_c27248482 _d27248482 |
||